NOD2 and lung carcinoma: It was also found that polymorphisms of NOD1/CARD4 may affect the diagnosis and treatment of lung cancer (Ozbayer et al., 2015), while polymorphisms of NOD2 were also associated with an increased risk of lung cancer (Liu J. et al., 2014).